Revista Cubana de Cardiología y Cirugía Cardiovascular, 2001 Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga +1 more
doaj
Differential inhibition of adenosine diphosphate– versus thrombin receptor–activating peptide–stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics [PDF]
, 2001 Artur‐Aron Weber, Karsten Schrör
openalex +1 more source
Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function [PDF]
, 2001 Eli I. Lev +9 more
openalex +1 more source
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects [PDF]
, 2001 Ute Klinkhardt +6 more
openalex +1 more source
A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab [PDF]
, 2001 Myung Ho Jeong +10 more
openalex +1 more source
CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY
, 1999 Vlasses Ph +5 more
openalex +1 more source
Comparison of eptifibatide and abciximab with decision analysis [PDF]
, 2001 Dorothy H. Wong
openalex +1 more source
Antiplatelet strategies: past, present, and future. [PDF]
J Thromb Haemost, 2023 Stanger L, Yamaguchi A, Holinstat M.
europepmc +1 more source
Costs and effects of combining stenting and abciximab (ReoPro®) in daily practice [PDF]
, 2001 J. E. F. Zwart-van Rijkom +5 more
openalex +1 more source